Wednesday, 23 January 2019

Dr. Reddy's launches Aspirin and Extended-Release Dipyridamole Capsules

27 December 2018 | News

Aggrenox is a trademark of Boehringer Ingelheim

Dr. Reddy’s has announced the launch of Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyridamole) Capsules in the United States market from the U.S. Food and Drug Administration (USFDA).

The Aggrenox brand and generic had U.S. sales of approximately $182 million MAT for the most recent twelve months ending in October 2018 according to IMS Health.

Dr. Reddy’s Aspirin and Extended-Release Dipyridamole Capsules is available in 25 mg/200 mg strength with 60 count bottle size. Aggrenox is a trademark of Boehringer Ingelheim.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account